I am interested in the impact of infections on maternal and child health including vertical transmission and its prevention, and health and outcomes of children and young people living with congenitally-acquired infection. Recent work within the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) has focused on the safety of antiretroviral therapy among pregnant women living with HIV, and I recently led a study of young people living with HIV in Ukraine (2015-17) which explored the characteristics and health outcomes of 10-24 year olds living with perinatally or recently acquired HIV. This work was funded by the International AIDS Society’s CIPHER initiative.

As part of recent work funded by the NHS Infectious Diseases in Pregnancy Screening Programme I coordinated an audit of the management of pregnant women with hepatitis B across England who began antenatal care in 2014 – results are informing optimisation of strategies to prevent vertically-acquired hepatitis B among babies born in the UK. As a member of the ZIKAction Horizon2020 consortium in 2016-19 I contributed to the development and coordination of pregnancy and paediatric cohorts in Jamaica, Haiti and Ecuador. I am currently working as a member of the PENTA-coordinated REACH H2020 project (2019-2021) which seeks to answer research questions relating to HIV and TB and hepatitis C co-infection in pregnancy and childhood in the Russian Federation.

I was recently awarded funding from the Academy of Medical Sciences Springboard scheme for a feasibility study to investigate approaches to understanding the consequences of congenital cytomegalovirus infection for child health.